Company Filing History:
Years Active: 2012
Title: Innovations in Cardiac Electroporation by Cushing Hamlen
Introduction
Cushing Hamlen is an accomplished inventor based in Edina, MN (US). He has made significant contributions to the field of cardiac medicine through his innovative patent. His work focuses on advancing techniques for cardiac tissue treatment, which can potentially improve patient outcomes.
Latest Patents
Cushing Hamlen holds a patent for "Systems and methods for cardiac tissue electroporation ablation." This patent describes cardiac electroporation ablation systems and methods in which pulsed, high voltage energy is delivered to induce electroporation of cells in cardiac tissue, followed by cell rupturing. In some embodiments, the delivered energy is biphasic, having a cycle time of not more than 500 microseconds. This innovative approach aims to enhance the effectiveness of cardiac treatments.
Career Highlights
Cushing Hamlen is associated with Medtronic, Inc., a leading company in medical technology. His work at Medtronic has allowed him to contribute to groundbreaking advancements in cardiac care. With a focus on improving patient safety and treatment efficacy, Hamlen's innovations are paving the way for future developments in the field.
Collaborations
Cushing Hamlen has collaborated with notable professionals in his field, including David E Francischelli and Mark T Stewart. These collaborations have fostered an environment of innovation and have led to the development of advanced medical technologies.
Conclusion
Cushing Hamlen's contributions to cardiac electroporation ablation represent a significant advancement in medical technology. His innovative patent and work at Medtronic, Inc. highlight his commitment to improving cardiac care. Through his efforts, he is making a lasting impact on the field of medicine.